New hope for kids with Arthritis-Related eye problems when standard treatments fail

This study tested whether the drug adalimumab could reduce eye inflammation in children with juvenile arthritis whose eye problems weren't helped by standard steroid drops and methotrexate. For the first two months, some children received adalimumab while others received a placebo, and researchers measured the change in eye inflammation. After that, children could continue taking adalimumab for up to a year to see how well it worked and how safe it was over a longer period.